Niagen Bioscience (NAGE) Non Operating Income (2010 - 2026)
Niagen Bioscience's (NAGE) quarterly Non Operating Income came in at $375000.0 in Q1 2026, down 18.3% year-on-year from $459000.0 in Q1 2025, and up 10.95% on a QoQ basis from $338000.0 in Q4 2025.
Niagen Bioscience (NAGE) Non Operating Income (2010 - 2026) Analysis & Trends
Niagen Bioscience (NAGE) has 15 years of Non Operating Income data on file, last reported at $375000.0 in Q1 2026.
- On a quarterly basis, Non Operating Income fell 18.3% year-over-year to $375000.0 in Q1 2026; TTM through Mar 2026 was $1.8 million, a 35.58% increase from a year earlier, with the FY2025 full-year figure at $1.9 million, up 69.44% from the prior year.
- Non Operating Income for Q1 2026 stood at $375000.0, up from $338000.0 in the prior quarter.
- Over the last five years, Non Operating Income for NAGE reached as high as $564000.0 in Q3 2025 and fell as low as $125000.0 in Q2 2023.
- Historically, Non Operating Income has averaged $334333.3 across 4 years, with a median of $310000.0 in 2023.
- Across the five-year window, Non Operating Income soared 129.05% in 2025 and declined 18.3% in 2026, its largest moves.
- Year by year, Non Operating Income stood at $282000.0 in 2023, then soared by 32.27% to $373000.0 in 2024, then declined by 9.38% to $338000.0 in 2025, then increased by 10.95% to $375000.0 in 2026.
- Per Business Quant data, the three most recent Non Operating Income figures were $375000.0 in Q1 2026, $338000.0 in Q4 2025, and $564000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non Op. Inc. (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | -9.22 Mn |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | - |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | - |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 188.30 Mn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | 5.75 Mn |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | -8.59 Mn |
| 10 | Niagen Bioscience | 253.47 Mn | 186.92 Mn | 19.98 Mn | 375,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 375,000.00 |
| Dec 31, 2025 | 338,000.00 |
| Sep 30, 2025 | 564,000.00 |
| Jun 30, 2025 | 552,000.00 |
| Mar 31, 2025 | 459,000.00 |
| Dec 31, 2024 | 373,000.00 |
| Sep 30, 2024 | 276,000.00 |
| Jun 30, 2024 | 241,000.00 |
| Mar 31, 2024 | 239,000.00 |
| Dec 31, 2023 | 282,000.00 |
| Sep 30, 2023 | 188,000.00 |
| Jun 30, 2023 | 125,000.00 |
| Jun 30, 2020 | -24,000.00 |
| Mar 31, 2020 | -12,000.00 |
| Dec 31, 2019 | 7,000.00 |
| Sep 30, 2019 | -314,000.00 |
| Jun 30, 2019 | -575,000.00 |
| Mar 31, 2019 | 35,000.00 |
| Dec 31, 2018 | 22,000.00 |
| Sep 30, 2018 | -9,000.00 |